JAK-Inhibitor Safety in Adolescents With AD Reported JAK-Inhibitor Safety in Adolescents With AD Reported

Longer-term safety data on two JAK inhibitors approved for treating atopic dermatitis in adolescents are accumulating.MDedge News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Dermatology News Source Type: news